Federated Hermes’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Federated Hermes’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-150,361	Closed	-$3.11M	–	2407
2019 Q4	$3.11M	Buy	+150,361	New	+$2.54M	0.01%	908
2015 Q2	–	Sell	-191	Closed	-$4K	–	2107
2015 Q1	$4K	Hold	191	–	–	﹤0.01%	1905
2014 Q4	$4K	Buy	+191	New	+$3.46K	﹤0.01%	1874

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Federated Hermes's FLXN Position: Q1 2020 in Review

Federated Hermes sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2020, closing a stake of 150,361 shares — an estimated $3.11M sold.

Federated Hermes first reported a position in FLXN in Q4 2014 and held it in 3 quarters. The position peaked at $3.11M in Q4 2019. 123 funds tracked by Wall St. Rank hold FLXN as of Q1 2020.

Federated Hermes reported no remaining Flexion Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
Federated Hermes sold 150,361 Flexion Therapeutics, Inc. shares in Q1 2020, an estimated $3.11M.
Federated Hermes first reported a position in Flexion Therapeutics, Inc. in Q4 2014 and held it in 3 quarters.
Federated Hermes's Flexion Therapeutics, Inc. position peaked at $3.11M in Q4 2019.
123 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2020.

Based on Federated Hermes's 13F filing for Q1 2020, filed 13 May 2020.